Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines

Leukemia

Volumn 10, Issue 2, 1996, Pages 271-278

  Dehmel, U ^a   Quentmeier, H ^a   Drexler, H G ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

bFGF; Cytokines; FLT3; GM CSF; IL 3; SCF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; CYTOKINE RECEPTOR; FLT3; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 3; MITOGENIC AGENT; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOGENESIS; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029883184     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229-1237.
2. Löwenberg B, Touw I. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281-292.
3. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 1989; 339: 27-30.
4. Nicola NA Hemopoietic cell growth factors and their receptors. Annu Rev Biochem 1989; 58: 45-77.
5. Callard R, Gearing A (eds). The Cytokine FactsBook, Academic Press: London, 1994.
6. Nicola NA (ed). Guidebook to Cytokines and their Receptors. Oxford University Press: Oxford, 1994.
7. Belka C, Brach MA, Herrmann F. The role of tyrosine kinases and their substrates in signal transmission of hematopoietic growth factors: a short review. Leukemia 1995; 9: 754-761.
8. Budel LM, Dong F, Löwenberg B, Touw IP. Hematopoietic growth factor receptors: structure variations and alternatives of receptor complex formation in normal hematopoiesis and in hematopoietic disorders. Leukemia 1995; 9: 553-561.
9. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-212.
10. Metcalf D. Hematopoietic regulators: Redundancy or subtlety Blood 1993; 82: 3515-3523.
11. Ihle JN et al. Signalling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 1994; 19: 222-227.
12. Cosman D et al. A new cytokine receptor superfamily. Trends Biochem Sci 1990; 15: 265-270.
13. Birg F Rosnet O, Carbuccia N, Birnbaum D. The expression of FMS KIT and FLT3 in hematopoietic malignancies. Leuk Lymphoma 1994; 13: 223-227.
14. Matthews W et al. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations Cell 1991; 65: 1143-1152.
15. Rosnet O, Marchetto S, DeLapeyrière O, Birnbaum D. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSFR1 family. Oncogene 1991; 6: 1641-1650.
16. Small D et al. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor stem cells. Proc Natl Acad Sci USA 1993; 91: 459-463.
17. Rosnet O, Mattéi MG, Marchetto S, Birnbaum D. Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics 1991; 9: 380-385.
18. Agnès F et al. Genomic structure of the downstream part of the human FLT3 gene: exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III. Gene 1994; 145: 283-288.
19. Birg F et al. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 1992; 80: 2584-2593.
20. DaSilva N et al. Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia 1994; 8: 885-888.
21. Lavagna C, Marchetto S, Birnbaum D, Rosnet O. Identification and characterization of a functional murine FLT3 isoform produced by exon skipping. J Biol Chem 1995; 270: 3165-3171.
22. Lyman SD et al. Characterization of the protein encoded by the flt-3 (flk-2) receptor-like tyrosine kinase gene. Oncogene 1993; 8: 815-822.
23. Maroc N et al. Biochemical characterization and analysis of the transforming potential of the flt-3/flk-2 receptor tyrosine kinases. Oncogene 1993; 8: 909-918
24. Rosnet O et al. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993; 82: 1110-1119.
25. Dosil M, Wang S, Lemischka I. Mitogenic signalling and substrate specificity of the flk-2/flt-3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol Cell Biol 1993; 13: 6572-6585.
26. Rottapel R et al. Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase. Oncogene 1994; 9: 1755-1765.
27. Zeigler FC et al Cellular and molecular characterization of the role of the FLK-2/FLT-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 1994; 84: 2422-2430.
28. Hannum C et al. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994. 368: 643-648.
29. Lyman SD et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993; 75: 1157-1167.
30. Lyman SD et al. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994; 83: 2795-2801.
31. Muench MO et al. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 1995; 85: 963-972.
32. Brasel K et al. Expression of the FLT3 receptor and its ligand on hematopoietic cells. Leukemia 1995; 9: 1212-1218.
33. Meierhoff C et al. Expression of FLT3-receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 1995; 9: 1368-1372.
34. Dehmel U et al. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells. Leukemia 1996; 10: 261-270.
35. Drexler HC, Gignac SM, Minowada J. Hematopoietic cell lines. In: Hay RJ, Park JG, Gazdar A (eds). Atlas of Human Tumor Cell Lines. Academic Press: Orlando, 1994, pp 213-250.
36. Drexler HG, MacLeod RAF, Borkhardt A, Janssen JWG. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia 1995; 9: 480-500.
37. Avanzi GC et al. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 1988; 69: 359-366.
38. Hu ZB et al. Establishment and characterization of the novel cytokine-responsive myeloid and monocytic leukemia cell lines MUTZ-2 and MUTZ-3. Leukemia (submitted).
39. Wang C et al. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia 1991; 5: 493-499.
40. Lange B et al. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 1987; 70: 192-199.
41. Mouthon MA et al Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryopoiesis. Blood 1994; 84: 1085-1097.
42. Chiba S et al. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. Blood 1991; 78: 2261-2268.
43. Rambaldi A et al. Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8). Blood 1993; 81: 1376-1383.
44. Oez S et al. Establishment and characterization of a granulocyte-macrophage colony-stimulating factor-dependent human myeloid cell line. Blood 1990; 76: 578-582.
45. Morgan DA, Gumucio DL, Brodsky I. Granulocyte-macrophage colony-stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 1991; 78: 2860-2871.
46. Tohyama K et al. Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome. Br J Haematol 1994; 87: 235-242.
47. Wang C, Curtis JE, Minden MD, McCulloch EA. Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia 1989; 3: 264-269.
48. Tohda S et al. Relationship between c-Kit expression and proliferation in acute myeloblastic leukemia cell lines. J Cell Physiol 1993; 154: 410-418.
49. Kitamura T et al. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1. Blood 1989; 73: 375-380.
50. Oval J, Jones OW, Montoya M, Taetle R. Characterization of a factor-dependent acute leukemia cell line with translocation (3;3) (q21;q26). Blood 1990; 76: 1369-1374.
51. Komatsu N et al. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 1991; 51: 341-348.
52. Drexler HG et al. DSM Catalogue of Human and Animal Cell Lines, 5th edn, Braunschweig, Germany, 1995.
53. Rosnet O et al The human FLT3/FLK2 hematopoietic receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 1996; 10: 238-248.
54. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6. 597-641.
55. Gabrilove JL et al. Basic fibroblast growth factor counteracts the suppressive effects of transforming growth factor-β1 on human myeloid progenitor cells. Blood 1993; 81: 909-915.
56. Allouche M. Basic fibroblast growth factor and hematopoiesis Leukemia 1995; 9: 937-942.
57. McKenna HJ et al. The effect of FLT3 ligand on primary acute human leukemias. Leukemia (submitted).
58. Winkler TH, Melchers F, Rolink AG. Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse. Blood 1995; 85: 2045-2051.